Clinical trial · Interventional
Impact of Art Therapy on Fatigue and Quality of Life of Patients Treated With Adjuvant Radiotherapy for Breast Cancer
NCT01331629CI-TRIAL-00026444ART-THERAPIEcompletedPhase 2 / Phase 3ClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to compare intervention by Art-therapy to standard care in patients treated with adjuvant radiotherapy for breast cancer and evaluate the fatigue.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| ART-THERAPIE | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- ART-THERAPIE
- description
- supported in art therapy with other supportive care available in the facility
- interventionNames
- Other: ART-THERAPIE
- type
- NO_INTERVENTION
- label
- standard group
- description
- standard care (supportive care available in each facility)
Primary outcomes (1)
- measure
- evaluate persistent fatigue
- timeFrame
- up to 12 months after radiotherapy
- description
- Estimate the decrease in the proportion of patients with persistent fatigue after one month of radiotherapy in patients receiving an approach from art therapy as a complement to standard care compared to those with care standard alone. Evaluated by auto-questionnary
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Breast cancer surgery (invasive or in situ) by conservative surgery * Age ≥ 18 years * Indication of adjuvant radiotherapy * Adjuvant chemotherapy allowed * Agreeing to participate in a clinical study * Able to participate in a clinical trial Exclusion Criteria: * Metastatic Breast Cancer * Personal history of breast cancer
References
Publications (0)
Data not yet available
No reference posted for this study.